{"DataElement":{"publicId":"4024953","version":"1","preferredName":"Molecular Neoplasm Profile Test Genetic Variation Prevalence Affected Integer::3 Point Likert Scale","preferredDefinition":"The 3 point Likert scale response regarding whether there was any impact on decision to request molecular tumor profiling tests based on the prevalence of the genetic variation.","longName":"MNPT_GN_VAR_AF_3_LIK","context":"LCC","contextVersion":"1","DataElementConcept":{"publicId":"4024782","version":"1","preferredName":"Molecular Neoplasm Profile Test Genetic Variation Prevalence","preferredDefinition":"Molecular; relating to or produced by or consisting of molecules._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._An analysis (often in graphical form) representing the extent to which something exhibits various characteristics._A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._Genetic Variation consists of deviation(s) in the nucleotide sequence of the genetic material of an individual from that typical of the group to which the individual belongs, or deviation(s) in the nucleotide sequence of the genetic material of offspring from that of its parents._The ratio (for a given time period) of the number of occurrences of a disease or event to the number of units at risk in the population.","longName":"MNP_TST_GEN_VAR_PREV","context":"LCC","contextVersion":"1","ObjectClass":{"publicId":"4024763","version":"1","preferredName":"Molecular Neoplasm Profile Test","preferredDefinition":"Molecular; relating to or produced by or consisting of molecules.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:An analysis (often in graphical form) representing the extent to which something exhibits various characteristics.:A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25574:C3262:C84385:C47891","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular","conceptCode":"C25574","definition":"Relating to or produced by or consisting of molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Profile","conceptCode":"C84385","definition":"An analysis (often in graphical form) representing the extent to which something exhibits various characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Test","conceptCode":"C47891","definition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDE9F5C2-EAB1-A461-E040-BB89AD43353E","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-19","modifiedBy":"ONEDATA","dateModified":"2013-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4024780","version":"1","preferredName":"Genetic Variation Prevalence","preferredDefinition":"The phenotypic differences among individuals in a population:The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.","longName":"C17248:C17010","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic Variation","conceptCode":"C17248","definition":"Genetic Variation consists of deviation(s) in the nucleotide sequence of the genetic material of an individual from that typical of the group to which the individual belongs, or deviation(s) in the nucleotide sequence of the genetic material of offspring from that of its parents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prevalence","conceptCode":"C17010","definition":"The ratio (for a given time period) of the number of occurrences of a disease or event to the number of units at risk in the population.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDEA3275-DEC9-1839-E040-BB89AD430288","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-19","modifiedBy":"ONEDATA","dateModified":"2013-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDEA3275-DEDA-1839-E040-BB89AD430288","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Molecular Tumor Profile. LCC. ghd. 12.19.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4011972","version":"1","preferredName":"Affected Integer::3 Point Likert Scale","preferredDefinition":"To be influenced by or changed._A number with no fractional part, including the negative and positive numbers as well as zero.::3_The precise location of something; a spatially limited location._A psychometric scale commonly used in questionnaires where a respondent is asked to evaluate an opinion according to subjective or objective criteria, by rating their level of agreement or disagreement with a statement._an ordered reference standard.","longName":"AFF_3PT_LKT_SCA","context":"LCC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"3","valueDescription":"High impact","ValueMeaning":{"publicId":"4011973","version":"1","preferredName":"High impact","longName":"4011973","preferredDefinition":"High impact","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDB12BD8-7026-DCD7-E040-BB89AD4338AF","latestVersionIndicator":"Yes","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EDB12BD8-703F-DCD7-E040-BB89AD4338AF","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"ONEDATA","dateModified":"2013-12-16","deletedIndicator":"No"},{"value":"2","valueDescription":"Moderate impact","ValueMeaning":{"publicId":"4011974","version":"1","preferredName":"Moderate impact","longName":"4011974","preferredDefinition":"Moderate impact","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDB12BD8-7049-DCD7-E040-BB89AD4338AF","latestVersionIndicator":"Yes","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EDB12BD8-7062-DCD7-E040-BB89AD4338AF","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"ONEDATA","dateModified":"2013-12-16","deletedIndicator":"No"},{"value":"1","valueDescription":"Little or no impact","ValueMeaning":{"publicId":"4011975","version":"1","preferredName":"Little or no impact","longName":"4011975","preferredDefinition":"Little or no impact","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDB12BD8-706C-DCD7-E040-BB89AD4338AF","latestVersionIndicator":"Yes","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EDB12BD8-7085-DCD7-E040-BB89AD4338AF","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"ONEDATA","dateModified":"2013-12-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4011971","version":"1","preferredName":"Affected Integer::3 Point Likert Scale Scale","preferredDefinition":"To be influenced by or changed.\r\n:A number with no fractional part, including the negative and positive numbers as well as zero.::3:The precise location of something; a spatially limited location.:A psychometric scale commonly used in questionnaires where a respondent is asked to evaluate an opinion according to subjective or objective criteria, by rating their level of agreement or disagreement with a statement.:an ordered reference standard.","longName":"4011971v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Affected","conceptCode":"C64917","definition":"To be influenced by or changed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Point","conceptCode":"C70656","definition":"The precise location of something; a spatially limited location.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Likert Scale","conceptCode":"C85429","definition":"A psychometric scale commonly used in questionnaires where a respondent is asked to evaluate an opinion according to subjective or objective criteria, by rating their level of agreement or disagreement with a statement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Scale","conceptCode":"C25664","definition":"An ordered reference standard used to measure incremental changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDB12BD8-7001-DCD7-E040-BB89AD4338AF","latestVersionIndicator":"Yes","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"ONEDATA","dateModified":"2013-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDB12BD8-7012-DCD7-E040-BB89AD4338AF","latestVersionIndicator":"Yes","beginDate":"2013-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-16","modifiedBy":"HARTLEYG","dateModified":"2013-12-20","changeDescription":"LCC_MolTumProf_ghd_12.16.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Prevalence of the genetic var","type":"Preferred Question Text","description":"Prevalence of the genetic variation","url":null,"context":"LCC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDEB579A-4E66-EA43-E040-BB89AD437984","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-19","modifiedBy":"HARTLEYG","dateModified":"2013-12-20","changeDescription":"Molecular Tumor Profiling Tests_LCC_ghd_12.19.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}